Next Article in Journal
Specific T-Cell Immune Response to SARS-CoV-2 Spike Protein over Time in Naïve and SARS-CoV-2 Previously Infected Subjects Vaccinated with BTN162b2
Next Article in Special Issue
Predictors of COVID-19 Vaccine Intention: Evidence from Chile, Mexico, and Colombia
Previous Article in Journal
Risk Factors and Incidence Rates of Self-Reported Short-Term Adverse Events of COVID-19 Vaccine Booster Dose
Previous Article in Special Issue
Trust in Science as a Possible Mediator between Different Antecedents and COVID-19 Booster Vaccination Intention: An Integration of Health Belief Model (HBM) and Theory of Planned Behavior (TPB)
 
 
Article

Article Versions Notes

Vaccines 2022, 10(7), 1116; https://doi.org/10.3390/vaccines10071116
Action Date Notes Link
article xml file uploaded 13 July 2022 11:59 CEST Original file -
article xml uploaded. 13 July 2022 11:59 CEST Update -
article pdf uploaded. 13 July 2022 11:59 CEST Version of Record https://www.mdpi.com/2076-393X/10/7/1116/pdf-vor
article html file updated 13 July 2022 12:00 CEST Original file -
article html file updated 13 July 2022 12:01 CEST Update -
article xml file uploaded 14 July 2022 10:46 CEST Update -
article xml uploaded. 14 July 2022 10:46 CEST Update https://www.mdpi.com/2076-393X/10/7/1116/xml
article pdf uploaded. 14 July 2022 10:46 CEST Updated version of record https://www.mdpi.com/2076-393X/10/7/1116/pdf
article html file updated 14 July 2022 10:47 CEST Update https://www.mdpi.com/2076-393X/10/7/1116/html
Back to TopTop